Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Costs of Anonymization: Case Study Using Clinical Data.
Pilgram L, Meurers T, Malin B, Schaeffner E, Eckardt KU, Prasser F; GCKD Investigators. Pilgram L, et al. J Med Internet Res. 2024 Apr 24;26:e49445. doi: 10.2196/49445. J Med Internet Res. 2024. PMID: 38657232 Free article.
Grainyhead-like 2 Deficiency and Kidney Cyst Growth in a Mouse Model.
Yurtdas ZY, Kilic E, Boor P, Wyler E, Landthaler M, Jung K, Schmidt-Ott KM. Yurtdas ZY, et al. Among authors: schmidt ott km. J Am Soc Nephrol. 2024 Apr 24. doi: 10.1681/ASN.0000000000000353. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 38656794
Epithelial cell states associated with kidney and allograft injury.
Hinze C, Lovric S, Halloran PF, Barasch J, Schmidt-Ott KM. Hinze C, et al. Among authors: schmidt ott km. Nat Rev Nephrol. 2024 Apr 17. doi: 10.1038/s41581-024-00834-0. Online ahead of print. Nat Rev Nephrol. 2024. PMID: 38632381 Review.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD.
Sommerer C, Müller-Krebs S, Nadal J, Schultheiss UT, Friedrich N, Nauck M, Schmid M, Nußhag C, Reiser J, Eckardt KU, Zeier M, Hayek SS; German Chronic Kidney Disease Investigators. Sommerer C, et al. Kidney Int Rep. 2023 Sep 9;8(11):2265-2275. doi: 10.1016/j.ekir.2023.08.038. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025216 Free PMC article.
[What is proven in treatment?].
Haller H, Schmidt-Ott K. Haller H, et al. Among authors: schmidt ott k. Inn Med (Heidelb). 2023 Dec;64(12):1133-1134. doi: 10.1007/s00108-023-01633-8. Epub 2023 Nov 23. Inn Med (Heidelb). 2023. PMID: 37994933 German. No abstract available.
119 results